肝癌破裂出血急诊TAE序贯手术切除联合腹腔热灌注化疗等综合治疗的研究分析

肝脏 ›› 2022, Vol. 27 ›› Issue (4): 455-459.

肝癌破裂出血急诊TAE序贯手术切除联合腹腔热灌注化疗等综合治疗的研究分析

段昌虎, 刘晓晨, 段建峰, 丁建龙, 赵李飞, 邰升

723000 陕西汉中西安交通大学医学部附属三二〇一医院肝胆胰脾外科(段昌虎,刘晓晨,段建峰,丁建龙,赵李飞);哈尔滨医科大学附属第二医院肝胆外科(邰升)

收稿日期:2021-09-10 出版日期:2022-04-30 发布日期:2022-06-02
通讯作者: 刘晓晨,Email:liuxiaochen@126.com
基金资助:
黑龙江省自然科学基金(H2018025)

The treatment of ruptured hepatocellular carcinoma by emergent TAE in combination with sequential resection or intraperitoneal hyperthermic perfusion chemotherapy

DUAN Chang-hu¹, LIU Xiao-chen¹, DUAN Jian-feng¹, DING Jian-long¹, ZHAO Li-fei¹, TAI Sheng²

1. Department of Hepatobiliary Surgery,3201 Hospital of Xi'an Jiaotong University Health Science Center,Hanzhong 723000, China;
2. Department of Hepatobiliary Surgery, the 2nd Affiliated Hospital of Harbin Medical University, Heilongjiang 150086, China

Received:2021-09-10 Online:2022-04-30 Published:2022-06-02
Contact: LIU Xiao-chen,Email:liuxiaochen@126.com

摘要/Abstract

摘要： 目的探讨肝癌破裂出血行急诊肝动脉栓塞(transcatheter arterial embolization,TAE)序贯手术切除联合腹腔热灌注化疗等综合治疗的临床价值。方法回顾性分析我院自2015年1月至2021年6月治疗的30例肝癌破裂出血患者的诊治过程,将患者分为TAE后外科手术治疗组(10例)及TAE后保守治疗组(20例),比较两组患者1年、2年、3年及5年生存率。结果外科手术组的1年生存率为70%,明显高于保守治疗组的35%,外科手术组的2年、3年、5年生存率为40%、20%、10%,保守治疗组为0,外科手术组的远期生存率明显高于保守治疗组。结论针对肝癌破裂出血且有外科适应证的患者,通过急诊TAE序贯外科手术,术后行综合治疗是可以取得满意效果的。

关键词: 肝癌, 破裂出血, 外科手术, 肝动脉栓塞术, 综合治疗

Abstract: Objective To investigate the clinical value of emergent transcatheter arterial embolization (TAE) in combination with sequential resection or conserved intraperitoneal hyperthermic perfusion chemotherapy for the treatment of ruptured hepatocellular carcinoma.Methods Thirty cases of ruptured hepatocellular carcinoma that were diagnosed and treated from January 2015 to June 2021 were retrospectively analyzed. The patients were divided into a surgical treatment group (10 cases) and a conservative treatment group (20 cases). The 1-, 2-, 3- and 5-year survival rates of the two groups were compared.Results The 1-year survival rate of the surgical treatment group was 70%, which was significantly higher than that of the conservative treatment group (35%). The 2-year, 3-year and 5-year survival rates of the surgical treatment group were 40%, 20% and 10%, which were 0% in the conservative treatment group. The long-term survival rate of the surgical group was significantly higher than that of the conservative treatment group.Conclusion For patients with ruptured hepatocellular carcinoma that have surgical indication, emergent TAE combined with sequential surgical resection followed by postoperative intraperitoneal hyperthermic perfusion chemotherapy and other combined treatments can achieve satisfactory prognosis.

Key words: hepatocellular carcinoma, ruptured, surgical resection, transcatheter arterial embolization, intraperitoneal hyperthermic perfusion chemotherapy, combined treatments

段昌虎, 刘晓晨, 段建峰, 丁建龙, 赵李飞, 邰升. 肝癌破裂出血急诊TAE序贯手术切除联合腹腔热灌注化疗等综合治疗的研究分析[J]. 肝脏, 2022, 27(4): 455-459.

DUAN Chang-hu, LIU Xiao-chen, DUAN Jian-feng, DING Jian-long, ZHAO Li-fei, TAI Sheng. The treatment of ruptured hepatocellular carcinoma by emergent TAE in combination with sequential resection or intraperitoneal hyperthermic perfusion chemotherapy[J]. Chinese Hepatolgy, 2022, 27(4): 455-459.

参考文献

[1] Sahu SK,Chawla YK,Dhiman RK,et al.Rupture of hepatocellular carcinoma: a review of literature.J Clin Exp Hepatol, 2019,9:245-256.
[2] 刘允怡.自发性肝细胞癌破裂的处理策略.中华消化外科杂志,2020,19:113-118.
[3] 尹兵,麻勇.肝癌破裂相关急腹症的诊治体会 .国际外科学杂志,2020,47:649-654.
[4] Demetrious M, Jeffery C, Steven HS, et al.Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review.J Surg Oncol,2018,117:341-353.
[5] 王新伟, 王维娜, 张宗利. 肝细胞癌自发性破裂出血行肝切除术的疗效及生存分析. 临床肝胆病杂志, 2019, 35: 114-118.
[6] Aoki T,Kokudo N,Matsuyama Y,et al.Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey.Ann Surg, 2014,259:532-542.
[7] Yang T, Sun YF, Zhang J, et al. Partial hepatectomy for ruptured hepatocellular carcinoma. Br J Surg, 2013,100:1071-1079.
[8] Wu JJ, Zhu P, Zhang ZG, et al. Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy. Eur J Surg Oncol,2019,45:1887-1894.
[9] Zhou SJ,Zhang EL,Liang BY,et al.Distilled Water Lavage During Surgery Improves Long-Term Outcomes of Patients with Ruptured Hepatocellular Carcinoma.J Gastrointest Surg,2015 ,19: 1262-1270.
[10] 李大伟, 王亚丽, 房芹. TACE术联合¹²⁵I放射性粒子植入序贯治疗HCC的预后及其影响因素. 肝脏, 2019, 24: 1258-1260.
[11] 中国医师协会肝癌专业员会精确放疗学组, 中国研究型医院学会放射肿瘤学专业委员会肝癌学组, 中国研究型医院学会肿瘤放射生物与多模态诊疗专业委员会, 等. 原发性肝癌放射治疗专家共识(2020年版). 临床肝胆病杂志, 2021, 37: 296-301.

[1]	李建, 成警花, 田杰, 李囿萱, 廖德仲, 徐静. HBV相关肝癌与非病毒相关肝癌临床特征对比分析[J]. 肝脏, 2022, 27(4): 460-465.
[2]	陈君耀, 黎才洋, 官宏勇. 多模态超声成像技术在肝癌高危人群筛查中综合运用策略研究[J]. 肝脏, 2022, 27(3): 288-291.
[3]	何文勇, 骆文志, 周鸿科. 肝癌治疗后并发胆管支气管瘘1例[J]. 肝脏, 2022, 27(3): 380-381.
[4]	冯权烨, 耿承军, 殷慧康. T2WI序列图像TA在肝硬化背景下结节及小肝癌鉴别诊断中的应用[J]. 肝脏, 2022, 27(2): 193-195.
[5]	王彬, 齐县伟, 张宪亮. US-CT/MRI融合成像技术用于原发性肝癌精准射频治疗中的价值[J]. 肝脏, 2022, 27(2): 199-202.
[6]	杨静仪, 勾熙, 毛小荣, 李俊峰. 肌肉减少症对终末期肝病临床结局和预后影响的研究进展[J]. 肝脏, 2022, 27(2): 245-247.
[7]	张昕, 吕丹, 刘丹阳. 肝硬化食管胃底静脉曲张破裂出血伴缺血性肝炎的危险因素分析[J]. 肝脏, 2022, 27(1): 47-50.
[8]	王秋, 林川. 糖尿病合并原发性肝癌患者介入术后感染发生状况及其影响因素分析[J]. 肝脏, 2022, 27(1): 76-80.
[9]	郑锐年, 孙成晖, 贾筠, 林顺欢, 林钦雄, 刘淳, 郝艳艳, 潘学兵, 何宇, 邵俊伟. Curcumin协同ABT-737对肝癌细胞上皮间质转化的抑制作用及相关机制初步研究[J]. 肝脏, 2022, 27(1): 86-90.
[10]	黎美琳, 姚上志, 王栋, 居峰, 王晓伟. 卡维地络联合内镜下精准食管胃静脉曲张断流术治疗食管胃静脉曲张破裂出血的疗效[J]. 肝脏, 2021, 26(9): 980-983.
[11]	郭智辈, 唐文才, 李小华, 汤富强, 张尾兰. CT三维重建在原发性肝癌肝脏切除术前肿瘤体积评估中的应用[J]. 肝脏, 2021, 26(9): 1003-1006.
[12]	陈超, 姚玲, 邱邦东, 王小燕. GP73与铁调素在HBV相关性肝癌患者血清中表达变化及与预后的相关性[J]. 肝脏, 2021, 26(9): 1007-1010.
[13]	李敏, 吴兴桂, 朱军华. circPDSS1通过靶向miR-1298调控肝癌细胞侵袭、迁移和凋亡的分子机制[J]. 肝脏, 2021, 26(9): 1011-1015.
[14]	孙文文, 张凌云. 叶酸代谢通路基因在肝癌中的表达及意义[J]. 肝脏, 2021, 26(8): 851-856.
[15]	朱翊, 赵萍, 李杰珍, 冉博. 术前NLR水平与原发性肝癌患者肝切除术后肝衰竭的相关性[J]. 肝脏, 2021, 26(8): 857-860.